|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5050 EUR | +4.27% |
|
-1.60% | -11.40% |
| 06-12 | CStone Pharmaceuticals Drug Receives Ethics Approval in Australia | MT |
| 06-11 | Cstone Presents Clinical Data for Cs2009 Trispecific Antibody At Asco 2026 | CI |
Chart: Technical Analysis
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 2616 Stock
- PH4 Stock
- Charts CStone Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
